Tasly Pharmaceutical Group Co Ltd
SSE:600535

Watchlist Manager
Tasly Pharmaceutical Group Co Ltd Logo
Tasly Pharmaceutical Group Co Ltd
SSE:600535
Watchlist
Price: 15.36 CNY 0.13% Market Closed
Market Cap: 22.9B CNY

Intrinsic Value

The intrinsic value of one Tasly Pharmaceutical Group Co Ltd stock under the Base Case scenario is 18.77 CNY. Compared to the current market price of 15.36 CNY, Tasly Pharmaceutical Group Co Ltd is Undervalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
18.77 CNY
Undervaluation 18%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Tasly Pharmaceutical Group Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Tasly Pharmaceutical Group Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Tasly Pharmaceutical Group Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Tasly Pharmaceutical Group Co Ltd
SSE:600535
CN
Pharmaceuticals
Market Cap
22.9B CNY
IPO
Aug 23, 2002
CN
Pharmaceuticals
Market Cap
22.9B CNY
IPO
Aug 23, 2002
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Tasly Pharmaceutical Group Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tasly Pharmaceutical Group Co Ltd

Current Assets 7.3B
Cash & Short-Term Investments 2.9B
Receivables 2B
Other Current Assets 2.4B
Non-Current Assets 7.7B
Long-Term Investments 1.9B
PP&E 3.7B
Intangibles 2B
Other Non-Current Assets 88.8m
Efficiency

Free Cash Flow Analysis
Tasly Pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Tasly Pharmaceutical Group Co Ltd

Revenue
8.5B CNY
Cost of Revenue
-2.9B CNY
Gross Profit
5.6B CNY
Operating Expenses
-4.4B CNY
Operating Income
1.2B CNY
Other Expenses
-230.8m CNY
Net Income
974.7m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Tasly Pharmaceutical Group Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive Revenue Growth Forecast
56/100
Profitability
Score

Tasly Pharmaceutical Group Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Tasly Pharmaceutical Group Co Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
82/100
Solvency
Score

Tasly Pharmaceutical Group Co Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Tasly Pharmaceutical Group Co Ltd

Wall Street analysts forecast Tasly Pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tasly Pharmaceutical Group Co Ltd is 16.46 CNY with a low forecast of 14.65 CNY and a high forecast of 18.82 CNY.

Lowest
Price Target
14.65 CNY
5% Downside
Average
Price Target
16.46 CNY
7% Upside
Highest
Price Target
18.82 CNY
23% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Tasly Pharmaceutical Group Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Tasly Pharmaceutical Group Co Ltd stock?

The intrinsic value of one Tasly Pharmaceutical Group Co Ltd stock under the Base Case scenario is 18.77 CNY.

Is Tasly Pharmaceutical Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 15.36 CNY, Tasly Pharmaceutical Group Co Ltd is Undervalued by 18%.

Back to Top